NEWARK, CA / ACCESS Newswire / January 7, 2026 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today ...

Apple has been on the hunt for a replacement card issuer ever since Goldman Sachs decided to abandon its push into retail ...

The AI in Retail Conference returns to New York on January 12, bringing senior retail and AI leaders together to ...

Banking giant JP Morgan has won a sex discrimination case against a female analyst who claimed she was paid less for doing ...

J.P. Morgan said on Monday it launched a new advisory unit to serve a select group of clients and widen their access to ...

J.P. Morgan's top defensive-growth idea, with shares expected to re-rate up "on robust EBITDA accretion from renewable ...

Taiwan Semiconductor Manufacturing stock has gained from it being the dominant AI chip manufacturer. Intel won’t challenge it ...

Morgan Stanley, a leading Wall Street investment bank, has confirmed its negative outlook, stating, “Regulatory risks for ...

32 Biosciences revealed its plan to launch a $40 million Series A at this year’s J.P Morgan Healthcare conference, to advance ...

JP Morgan says it prefers UOB to OCBC because UOB has looked ahead in terms of credit risks during the 3Q2025 review, so that ...

J.P. Morgan’s top pick energy stocks for 2026 have secular growth drivers, robust balance sheets, and exposure to ...